Condition: Solid Tumors, Adult · Sponsor: Hutchmed
This is a first-in-human, multicenter, open-label, phase I/Ⅱa clinical study of HMPL-A580 in participants with unresectable, advanced or metastatic solid tumors.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| University of California Irvine Medical Center | Orange, California, United States | Not Yet Recruiting |
| BRCR Global | Plantation, Florida, United States | Not Yet Recruiting |
| Florida Clinical Trials Group LLC (Plantation) | Plantation, Florida, United States | Not Yet Recruiting |
| Florida Clinical Trials Group LLC (Tamarac) | Tamarac, Florida, United States | Not Yet Recruiting |
| University of Washington/Fred Hutchinson Cancer Center | Seattle, Washington, United States | Not Yet Recruiting |
| Hunan Cancer Hospital | Changsha, China | Not Yet Recruiting |
| Guangxi Medical University Cancer Hospital | Nanning, China | Not Yet Recruiting |
| Shanghai East Hospital | Shanghai, China | Recruiting |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan, China | Not Yet Recruiting |
| The First Affiliated Hospital of Xiamen University | Xiamen, China | Not Yet Recruiting |
| Henan Cancer Hospital | Zhengzhou, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07396584